-
ICD-10-CM Codes
›
-
E00-E89
›
-
E20-E35
›
-
E31-
›
-
2023 ICD-10-CM Diagnosis Code E31
2023 ICD-10-CM Diagnosis Code E31
Polyglandular dysfunction
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
- E31 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2023 edition of ICD-10-CM E31 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E31 - other international versions of ICD-10 E31 may differ.
Type 1 ExcludesType 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as E31. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- ataxia telangiectasia [Louis-Bar] (
ICD-10-CM Diagnosis Code G11.3
Cerebellar ataxia with defective DNA repair
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Ataxia telangiectasia [Louis-Bar]
Type 2 Excludes- Cockayne's syndrome (Q87.19)
- other disorders of purine and pyrimidine metabolism (E79.-)
- xeroderma pigmentosum (Q82.1)
G11.3) - dystrophia myotonica [Steinert] (
ICD-10-CM Diagnosis Code G71.11
Myotonic muscular dystrophy
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Dystrophia myotonica [Steinert]
- Myotonia atrophica
- Myotonic dystrophy
- Proximal myotonic myopathy (PROMM)
- Steinert disease
G71.11) - pseudohypoparathyroidism (
ICD-10-CM Diagnosis Code E20.1
Pseudohypoparathyroidism
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
E20.1)
The following code(s) above
E31 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
E31:
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
ICD-10-CM Codes Adjacent To E31
E29 Testicular dysfunction
E29.0 Testicular hyperfunction
E29.1 Testicular hypofunction
E29.8 Other testicular dysfunction
E29.9 Testicular dysfunction, unspecified
E30 Disorders of puberty, not elsewhere classified
E30.8 Other disorders of puberty
E30.9 Disorder of puberty, unspecified
E31
Polyglandular dysfunction
E31.0 Autoimmune polyglandular failure
E31.1 Polyglandular hyperfunction
E31.2 Multiple endocrine neoplasia [MEN] syndromes
E31.20 Multiple endocrine neoplasia [MEN] syndrome, unspecified
E31.21 Multiple endocrine neoplasia [MEN] type I
E31.22 Multiple endocrine neoplasia [MEN] type IIA
E31.23 Multiple endocrine neoplasia [MEN] type IIB
E31.8 Other polyglandular dysfunction
E31.9 Polyglandular dysfunction, unspecified
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.